| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9117813 | Metabolism | 2005 | 5 Pages |
Abstract
Metformin is able to reverse insulin resistance and hyperglycemia in high-risk subjects for type 2 diabetes mellitus independently of the effects on tumor necrosis factor α system activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Josefina Biarnés, José Manuel Fernández-Real, Miguel Fernández-Castañer, Maria del Mar GarcÃa, Juan Soler, Wilfredo Ricart,